HBP-bound doxorubicin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHBP-bound doxorubicin
Drug Alias Namehydroxybisphosphonate-conjugated doxorubicinbone-targeting antineoplastic agent12b80
ClassificationSmall molecules
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsDNATopoisomerase II
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A